Navigation Links
A New Addition Could Help Patients With Parkinson’s Disease

Researchers say by adding the drug rasagiline to standard treatment with levodopa can reduce the amount of time Parkinson’s disease // patients spend suffering from motor fluctuations they experience during the day .

For the study researchers compared once-daily oral rasagiline to the drug entacapone, which must be taken with every levodopa dose, and a placebo in around 690 patients. Both of the additional drugs were effective in reducing the amount of “off time” defined as periods during the day when patients have symptoms. Rasagiline reduced “off time” on average by 1.18 hours, compared to 1.2 hours for entacapone. The drug was also found to be well-tolerated in the older age groups, with no evidence of an increase in hallucinations or occurrence of other common side effects of Parkinson’s drugs, such as daytime sleepiness, nausea, and leg swelling.

In conclusion researchers say they feel that the drug is likely to find favor with both neurologists and geriatricians as a useful addition to Parkinson’s disease therapeuics.

Page: 1

Related medicine news :

1. Additional Radiotheraphy for Breast Cancer
2. Adding An Additional Drug May Help Patients With Glaucoma
3. The Addition Of Radiation Therapy Found To Improve Survival In Breast Cancer Patients
4. Addition Of Folic Acid In Flour Proposed To Arrest Birth Defects In The UK
5. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
6. Britain Toddlers To Receive Flu-Jab In Addition To The 21 Shots
7. No More Additional Cases of Mad Cow Disease in Canada
8. Killing Power Of Bleach Enhanced By Addition Of Vinegar
9. Tackling Drug Addition in UK
10. Kellogg’s Additions to Wholesome Snack
11. NACO to Introduce 400 Additional AIDS/HIV Screening Centers
Post Your Comments:

(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group ... Tournament held on June 20th at the Woodmont Country Club at 1201 Rockville ... an organization dedicated to helping service members that have been wounded in battle and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: